Why This Matters
Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist used widely for diabetes and weight management, has gained attention for its benefits in metabolic health. However, its potential impact on surgical outcomes, especially in spine surgery, is now under scrutiny. This study provides the first evidence linking semaglutide to a significantly increased risk of repeat lumbar surgeries, raising important considerations for surgical planning and postoperative care in diabetic patients.
What the Research Found
A retrospective analysis using the Mariner database examined outcomes in 1781 patients with type 2 diabetes who underwent elective one- to three-level transforaminal lumbar interbody fusions (TLIFs) between 2018 and 2022. Of these, 447 were semaglutide users. Despite fewer surgical complications like wound infections and hematomas, semaglutide users were nearly 12 times more likely to require additional lumbar surgery within one year (27.3% vs 3.1%). The longer patients were on semaglutide, the higher their risk appeared to be. Medical complications such as urinary tract infections and acute kidney injury were also more common in the semaglutide group.
The authors suspect sarcopenia related to weight loss may contribute to mechanical instability postoperatively, prompting further surgery. A similar trend was noted in nondiabetic patients using semaglutide for obesity, though those findings are still under review.
Clinical Takeaways
-
- Diabetic patients on semaglutide undergoing lumbar fusion have a markedly higher risk of revision surgery within one year.
- Consider preoperative evaluation for sarcopenia and bone health in these patients.
- Monitor closely for medical complications such as UTIs and acute kidney injury postoperatively.
- Surgical complications (e.g., wound issues, infections) may be lower, but mechanical outcomes could be compromised.
- Timing and dosing of semaglutide around surgery may need to be reassessed as further evidence emerges.
Where Collaborative Spine Care May Support This
Chiropractic or manual therapy teams may play a role in preoperative conditioning and postoperative rehabilitation to support muscle strength and mitigate sarcopenia-related risks in patients on semaglutide.
Reference
Khalid SI, et al. Increased Risk for Repeat Lumbar Surgeries in Semaglutide Users with Diabetes. Presented at: American Association of Neurological Surgeons (AANS) 2024 Annual Meeting; May 3, 2024; Chicago, IL. https://www.medscape.com/viewarticle/semaglutide-repeat-spine-surgery